CIVIL ACTION FILED AGAINST EPITOPE
CIVIL ACTION FILED AGAINST EPITOPE BEAVERTON, Ore., June 21 /PRNewswire/ -- Epitope, Inc.
(AMEX: EPT), announced that it has been served with a complaint filed in the U.S. District Court for the District of Oregon by a plaintiff who seeks to represent a purported class of Epitope shareholders. The complaint seeks unspecified damages from the company and certain of its executive officers and directors based on alleged misstatements and omissions related to the company's application for FDA approval of its OraSure(R) product.
"We believe the allegations contained in the complaint are based on an unfortunate misinterpretation of statements taken out of context from internal FDA documents. The company is discussing the complaint with counsel and intends to vigorously defend the action," said Adolph J. Ferro, Epitope's president and chief executive officer. -0- 6/21/92 /CONTACT: Mary Hagen, 503-641-6115 or Shari Annes, 415-726-5400, both of Epitope/ (EPT) CO: Epitope, Inc. ST: Oregon IN: MTC SU:
JP -- NYONS1 -- 2185 06/21/92 21:45 EDT
|Printer friendly Cite/link Email Feedback|
|Date:||Jun 21, 1992|
|Previous Article:||'BATMAN RETURNS' SOARS WITH HISTORY-MAKING $46.5 MILLION OPENING|
|Next Article:||NEW SCHERING-PLOUGH BROCHURE PROVIDES SOLUTION TO SUMMER SKIN PROBLEMS|